NCT00882700View on ClinicalTrials.gov

To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicef 300 mg Capsule Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
Healthy
Interventions
DRUG

Cefdinir 300 mg Capsule (Sandoz, Austria)

DRUG

Omnicef Cefdinir 300 mg Capsule (Abbott Laboratories, USA)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY

NCT00882700 - To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicef 300 mg Capsule Fasting Conditions | Biotech Hunter | Biotech Hunter